Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study (Q37604504)
Jump to navigation
Jump to search
scientific article published on 07 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study |
scientific article published on 07 June 2016 |
Statements
1 reference
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study (English)
1 reference
Marco Gattorno
1 reference
Marco Cattalini
1 reference
Vincent Tormey
1 reference
Ken Abrams
1 reference
Nicole Davis
1 reference
Antonio Speziale
1 reference
Suraj G Bhansali
1 reference
Alberto Martini
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference